Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Michalowski Website

Aleksandra M. Michalowski, M.Sc., Ph.D.

Selected Publications

1)  Simmons JK, Patel J, Michalowski A, Zhang S, Wei BR, Sullivan P, Gamache B, Felsenstein K, Kuehl WM, Simpson RM, Zingone A, Landgren O, Mock BA.
TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms.
Mol Oncol. 8: 261-72, 2014.
2)  Bennett CN, Tomlinson CC, Michalowski AM, Chu IM, Luger D, Mittereder LR, Aprelikova O, Shou J, Piwinica-Worms H, Caplen NJ, Hollingshead MG, Green JE.
Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer.
Breast Cancer Res. 14: R109, 2012.
3)  Chu IM, Michalowski AM, Hoenerhoff M, Szauter KM, Luger D, Sato M, Flanders K, Oshima A, Csiszar K, Green JE.
GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells.
Oncogene. 31: 2017-27, 2012.
4)  Webster JD, Michalowski AM, Dwyer JE, Corps KN, Wei BR, Juopperi T, Hoover SB, Simpson RM.
Investigation into diagnostic agreement using automated computer-assisted histopathology pattern recognition image analysis.
J Pathol Inform. 3: 18, 2012.
5)  Lee KH, Li M, Michalowski AM, Zhang X, Liao H, Chen L, Xu Y, Wu X, Huang J.
A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells.
Proc. Natl. Acad. Sci. U.S.A. 107: 69-74, 2010.
6)  Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, Davis AS, Webster JD, Hoover S, Simpson RM, Gauldie J, Green JE.
Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment.
Cancer Res. 70: 5706-16, 2010.
7)  Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff MJ, Kavanaugh C, Li MC, Demayo FJ, Linnoila I, Deng CX, Lee EY, Medina D, Shih JH, Green JE.
Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
Cancer Res. 67: 8065-80, 2007.
8)  Shih JH, Michalowska AM, Dobbin K, Ye Y, Qiu TH, Green JE.
Effects of pooling mRNA in microarray class comparisons.
Bioinformatics. 20: 3318-25, 2004.
9)  McShane LM, Shih JH, Michalowska AM.
Statistical issues in the design and analysis of gene expression microarray studies of animal models.
J Mammary Gland Biol Neoplasia. 8: 359-74, 2003.
Click Here to View Expanded Bibliography.

This page was last updated on 7/9/2014.